What is the main reason behind the massive exodus of companies from Kenya? Here is a detailed look as to why some global ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

Request To Download Sample of This Strategic Report @ Rising cases of thyroid cancer is expected to drive the market. According to National Cancer Institute about 1.2% of men and women are detected ...

With the pharmaceutical industry aiming to grow from $58 billion to $130 billion by 2030, he highlighted significant ...

PRNewswire New Delhi [India] November 28 The Organisation of Pharmaceutical Producers of India OPPI organized its flagship ...

Patients in low and middle-income countries (LMICs) are largely excluded from clinical trials by pharmaceutical companies, ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...

(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation.

Pitcairn Co. cut its holdings in GSK plc (NYSE:GSK – Free Report) by 14.1% during the 3rd quarter, according to its most ...

GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...